Omadacycline tosylate

甲苯磺酸奥马环素

Report date: 2026/05/26 20:00:28
NMEQIDP

Base Information

Drug NameOmadacycline tosylate
Drug Alias Name奥玛环素omadacyclineomadacyclinum甲苯磺酸奥玛环素Amadacycline +[18] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsCommunity Acquired PneumoniaCommunity-acquired bacterial pneumoniaAcute bacterial skin and skin structure infections +[17] 
Global Approved IndicationsCommunity-acquired bacterial pneumoniaAcute bacterial skin and skin structure infectionsSkin Diseases, Bacterial +[5] 
Approved Indications in ChinaCommunity-acquired bacterial pneumoniaAcute bacterial skin and skin structure infections
Original Approved Country/TerritoryUnited States
Original Approved Date2018/10/02
Country/TerritoryCzechiaBelgiumBulgaria +[27] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesParatek Pharmaceutical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZai Lab (Hong Kong) LtdParatek Pharmaceuticals IncZai Lab (Shanghai) Co Ltd +[7] 
Inactive CompaniesBiopharmx IncHangzhou Ausia Biological Technology Co Ltd
Active IndicationsCommunity Acquired PneumoniaCommunity-acquired bacterial pneumoniaAcute bacterial skin and skin structure infections +[11] 
Inactive IndicationsRosaceaCystitisUrinary Tract Infections +[6] 

Other Information

ATC CodeJ01AA15
Related LinksWikipediaDrugBankKEGG